Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,594 | -130,302 | -101,744 | -108,176 | -58,235 |
| Depreciation Amortization | -407 | -2,118 | -979 | 1,608 | 897 |
| Accounts receivable | N/A | N/A | 2,000 | N/A | N/A |
| Accounts payable and accrued liabilities | -825 | -1,184 | -1,705 | 1,097 | 1,232 |
| Other Working Capital | -67,199 | -31,746 | -37,966 | -18,493 | -11,345 |
| Other Operating Activity | 31,139 | 33,849 | 22,412 | 14,884 | 7,924 |
| Operating Cash Flow | $-138,886 | $-131,501 | $-117,982 | $-109,080 | $-59,527 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,048 | -754 | -1,526 | -7,692 | -1,837 |
| Purchase Of Investment | -264,457 | -240,888 | -310,574 | -208,504 | -372,361 |
| Sale Of Investment | 224,640 | 327,768 | 353,526 | 242,595 | 190,764 |
| Investing Cash Flow | $-40,865 | $86,126 | $41,426 | $26,399 | $-183,434 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 222,536 | 47,664 | 81,958 | 1,623 | 1,058 |
| Other Financing Activity | -36 | 0 | 448 | -8 | 356,267 |
| Financing Cash Flow | $222,500 | $47,664 | $82,406 | $1,615 | $357,325 |
| Beginning Cash Position | 72,097 | 69,808 | 63,958 | 145,024 | 30,660 |
| End Cash Position | 114,846 | 72,097 | 69,808 | 63,958 | 145,024 |
| Net Cash Flow | $42,749 | $2,289 | $5,850 | $-81,066 | $114,364 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,886 | -131,501 | -117,982 | -109,080 | -59,527 |
| Capital Expenditure | -1,048 | -754 | -1,526 | -7,692 | -1,837 |
| Free Cash Flow | -139,934 | -132,255 | -119,508 | -116,772 | -61,364 |